Marie Skłodowska-Curie Doctoral Network (HER-CARE)
Host organisation: Proteotype Diagnostics Ltd (UK)
Academic partner: Medical University of Vienna (Austria)
Position: Doctoral Candidate (DC14)
Duration: 36 months
Expected start date: Autumn 2026
Proteotype Diagnostics is recruiting a Doctoral Candidate (DC14) as part of the HER-CARE Marie Skłodowska-Curie Doctoral Network, a European programme training the next generation of researchers in hereditary and early-stage breast cancer.
The project will focus on the development of circulating proteomic biomarkers for early breast cancer detection and prediction of treatment response, using Proteotype’s proprietary biomarker platform.
The doctoral candidate will:
- Investigate detection of early-stage (Stage I–III) breast cancer
- Analyse biomarker dynamics during systemic and neoadjuvant therapies
- Predict pathological complete response (pCR)
- Integrate proteomic, clinical, and epidemiological datasets
- Contribute to translational and mechanistic understanding of biomarker signals
Selected samples will also undergo advanced LC-MS proteomic analysis in collaboration with the Medical University of Vienna.
The doctoral candidate will:
- Be employed by Proteotype Diagnostics
- Be enrolled as a PhD candidate at the Medical University of Vienna
- Be supervised by Dr. Yen Tan (primary academic supervisor)
- Receive industrial supervision from Proteotype
- Participate in the HER-CARE doctoral training programme, including international collaboration and secondments
We are seeking a highly motivated candidate with strong quantitative and interdisciplinary skills.
Essential:
- MSc (or equivalent) in bioinformatics, computational biology, molecular biology, biomedical sciences, data science or related field
- Experience in data analysis, statistics, or computational methods
- Programming skills in Python, R or similar
- Interest in translational cancer research and biomarker development
Desirable:
- Experience in proteomics, machine learning, or multi-omics data integration
- Background in oncology or clinical data analysis
Applicants must:
- Not already hold a doctoral degree (PhD)
- Be eligible to enrol in a PhD programme at the Medical University of Vienna
Mobility rule (mandatory): Applicants must not have resided or carried out their main activity (work, studies, etc.) in the United Kingdom for more than 12 months in the 36 months immediately before the recruitment date.
- Fully funded 36-month doctoral position
- Salary and benefits in line with MSCA Doctoral Network funding rules
- Interdisciplinary research training across Europe
- Collaboration with leading academic and clinical partners
- Opportunity to work on cutting-edge liquid biopsy technologies
- Recruitment is starting immediately for an Autumn 2026 start date.
- To apply, navigate to https://proteotype.com/careers
- The position will also be advertised via EURAXESS and HER-CARE recruitment channels.
This project is funded by the European Union under the Marie Skłodowska-Curie Actions (MSCA).